Ritonavir
- Product NDC
- 70518-1519
- 11-digit product format
- 705181519
- Labeler code
- 70518
- Product ID
- 70518-1519_93fc284f-8bac-d500-e053-2a95a90ab701
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ritonavir
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA204587
- Marketing category
- ANDA
- Marketing start
- 2018-10-11
- Marketing end
- 0000-00-00
- Substance
- RITONAVIR
- Active strength
- 100 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Cytochrome P450 3A Inhibitor [EPC],Protease Inhibitor [EPC],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Cytochrome P450 2C19 Inducers [MoA],Cytochrome P450 3A Inducers [MoA],P-Glycoprotein Inhibitors [MoA],Breast Cancer Resistance Protein Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],UDP Glucuronosyltransferases Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record